Evidence map›Paper›PMID 35195741›Full record

ArticleAnalytical and bioanalytical chemistry2022

A novel fluorescence ratio probe based on dual-emission carbon dots for highly selective and sensitive detection of chlortetracycline and cell imaging.

Yu-Qi Liang, Xiao-Yi Wu, Jia-Yu Zeng, Yan-Ni Wu, Jia-Ping Lai, Hui Sun

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. GlutathioneNanoscale advances · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yu-Qi LiangSchool of Chemistry, South China Normal University, Guangzhou, 510006, China.
Xiao-Yi WuSchool of Chemistry, South China Normal University, Guangzhou, 510006, China.
Jia-Yu ZengSchool of Chemistry, South China Normal University, Guangzhou, 510006, China.
Yan-Ni WuSchool of Chemistry, South China Normal University, Guangzhou, 510006, China.
Jia-Ping LaiSchool of Chemistry, South China Normal University, Guangzhou, 510006, China. 20081223@m.scnu.edu.cn.
Hui SunCollege of Environmental Science & Engineering, Guangzhou University, Guangzhou, 510006, China. esesunhui@gzhu.edu.cn.
South China Normal University · CNGuangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel dual-emission carbon dots (DECDs) for highly selective and sensitive recognition of chlortetracycline (CTC) and cell imaging were synthesized successfully by one-step synthesis. The obtained DECDs possessed two fluorescence peaks (345 nm and 450 nm) and showed specific response to CTC, resulting in a decrease in fluorescence intensity at 345 nm, a blue shift, and an increase in fluorescence intensity at 450 nm. The obtained DECDs exhibited highly selective response to CTC and not to its analogues, such as tetracycline, doxycycline, and oxytetracycline. Thus, an excellent ratiometric probe for the detection of CTC was fabricated successfully and used for the detection of CTC in real samples with the detection limit (LOD) of 16.45 nM. More importantly, the DECDs were used for quantitative detection of CTC in living cells, which demonstrated excellent biocompatibility and broad prospects in biomedicine application. Finally, the excellent selectivity of DECDs toward CTC was attributed to the FRET mechanism and the formation of complexes.

Indexed as

ChlortetracyclineQuantum DotsCarbonFluorescent DyesLimit of DetectionCarbonChlortetracyclineFluorescent DyesCell imagingChlortetracyclineDual-emission carbon quantum dotsHigh selectivityRatiometric fluorescence

Identifiers

PMID35195741
OpenAlexW4212870280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.